Calla Lily Clinical Care Headquarters & Office Locations

Calla Lily Clinical Care is headquartered in England, United Kingdom. Founded in 2021, the company has 2 recorded locations and employs approximately 28 people worldwide.

What does Calla Lily Clinical Care do?

Calla Lily Clinical Care is a women’s health focused B-Corp that has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in fertility and pregnancy, where the company seeks to offer the world’s first drug-device combo product to prevent miscarriages, and for IVF luteal phase support. Callavid® can also deliver live biotherapeutics (LBPs) to reduce recurrent Bacterial Vaginosis, cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). Further use-cases include HRT for menopause use cases, and effective medical sample collection (Lilyvid™ device) to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a wide range of other conditions. The company’s devices are built upon underlying technology named a TIME Magazine Best Invention of the Year.